BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 21406728)

  • 1. The RP-Mdm2-p53 pathway and tumorigenesis.
    Miliani de Marval PL; Zhang Y
    Oncotarget; 2011 Mar; 2(3):234-8. PubMed ID: 21406728
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An ARF-independent c-MYC-activated tumor suppression pathway mediated by ribosomal protein-Mdm2 Interaction.
    Macias E; Jin A; Deisenroth C; Bhat K; Mao H; Lindström MS; Zhang Y
    Cancer Cell; 2010 Sep; 18(3):231-43. PubMed ID: 20832751
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disruption of the RP-MDM2-p53 pathway accelerates APC loss-induced colorectal tumorigenesis.
    Liu S; Tackmann NR; Yang J; Zhang Y
    Oncogene; 2017 Mar; 36(10):1374-1383. PubMed ID: 27617574
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mice with a Mutation in the Mdm2 Gene That Interferes with MDM2/Ribosomal Protein Binding Develop a Defect in Erythropoiesis.
    Kamio T; Gu BW; Olson TS; Zhang Y; Mason PJ; Bessler M
    PLoS One; 2016; 11(4):e0152263. PubMed ID: 27042854
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The in vivo role of the RP-Mdm2-p53 pathway in signaling oncogenic stress induced by pRb inactivation and Ras overexpression.
    Pan W; Issaq S; Zhang Y
    PLoS One; 2011; 6(6):e21625. PubMed ID: 21747916
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cancer-associated mutations in the MDM2 zinc finger domain disrupt ribosomal protein interaction and attenuate MDM2-induced p53 degradation.
    Lindström MS; Jin A; Deisenroth C; White Wolf G; Zhang Y
    Mol Cell Biol; 2007 Feb; 27(3):1056-68. PubMed ID: 17116689
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ribosomal protein RPL11 haploinsufficiency causes anemia in mice via activation of the RP-MDM2-p53 pathway.
    Franklin DA; Liu S; Jin A; Cui P; Guo Z; Arend KC; Moorman NJ; He S; Wang GG; Wan YY; Zhang Y
    J Biol Chem; 2023 Jan; 299(1):102739. PubMed ID: 36435197
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oncogenic c-Myc-induced lymphomagenesis is inhibited non-redundantly by the p19Arf-Mdm2-p53 and RP-Mdm2-p53 pathways.
    Meng X; Carlson NR; Dong J; Zhang Y
    Oncogene; 2015 Nov; 34(46):5709-17. PubMed ID: 25823025
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ribosomal protein-Mdm2-p53 pathway coordinates nutrient stress with lipid metabolism by regulating MCD and promoting fatty acid oxidation.
    Liu Y; He Y; Jin A; Tikunov AP; Zhou L; Tollini LA; Leslie P; Kim TH; Li LO; Coleman RA; Gu Z; Chen YQ; Macdonald JM; Graves LM; Zhang Y
    Proc Natl Acad Sci U S A; 2014 Jun; 111(23):E2414-22. PubMed ID: 24872453
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Signaling to p53: ribosomal proteins find their way.
    Zhang Y; Lu H
    Cancer Cell; 2009 Nov; 16(5):369-77. PubMed ID: 19878869
    [TBL] [Abstract][Full Text] [Related]  

  • 11. GRWD1 negatively regulates p53 via the RPL11-MDM2 pathway and promotes tumorigenesis.
    Kayama K; Watanabe S; Takafuji T; Tsuji T; Hironaka K; Matsumoto M; Nakayama KI; Enari M; Kohno T; Shiraishi K; Kiyono T; Yoshida K; Sugimoto N; Fujita M
    EMBO Rep; 2017 Jan; 18(1):123-137. PubMed ID: 27856536
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ribosomal protein S2 interplays with MDM2 to induce p53.
    Cho J; Park J; Shin SC; Kim JH; Kim EE; Song EJ
    Biochem Biophys Res Commun; 2020 Mar; 523(2):542-547. PubMed ID: 31928715
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RP-MDM2-p53 Pathway: Linking Ribosomal Biogenesis and Tumor Surveillance.
    Liu Y; Deisenroth C; Zhang Y
    Trends Cancer; 2016 Apr; 2(4):191-204. PubMed ID: 28741571
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ribosomal proteins RPL37, RPS15 and RPS20 regulate the Mdm2-p53-MdmX network.
    Daftuar L; Zhu Y; Jacq X; Prives C
    PLoS One; 2013; 8(7):e68667. PubMed ID: 23874713
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Putting a finger on growth surveillance: insight into MDM2 zinc finger-ribosomal protein interactions.
    Lindström MS; Deisenroth C; Zhang Y
    Cell Cycle; 2007 Feb; 6(4):434-7. PubMed ID: 17329973
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ribosomal protein S7 is both a regulator and a substrate of MDM2.
    Zhu Y; Poyurovsky MV; Li Y; Biderman L; Stahl J; Jacq X; Prives C
    Mol Cell; 2009 Aug; 35(3):316-26. PubMed ID: 19683495
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SPIN1 promotes tumorigenesis by blocking the uL18 (universal large ribosomal subunit protein 18)-MDM2-p53 pathway in human cancer.
    Fang Z; Cao B; Liao JM; Deng J; Plummer KD; Liao P; Liu T; Zhang W; Zhang K; Li L; Margolin D; Zeng SX; Xiong J; Lu H
    Elife; 2018 Mar; 7():. PubMed ID: 29547122
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ribosomal proteins as unrevealed caretakers for cellular stress and genomic instability.
    Kim TH; Leslie P; Zhang Y
    Oncotarget; 2014 Feb; 5(4):860-71. PubMed ID: 24658219
    [TBL] [Abstract][Full Text] [Related]  

  • 19. RPL23 Links Oncogenic RAS Signaling to p53-Mediated Tumor Suppression.
    Meng X; Tackmann NR; Liu S; Yang J; Dong J; Wu C; Cox AD; Zhang Y
    Cancer Res; 2016 Sep; 76(17):5030-9. PubMed ID: 27402081
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LUCAT1 promotes colorectal cancer tumorigenesis by targeting the ribosomal protein L40-MDM2-p53 pathway through binding with UBA52.
    Zhou Q; Hou Z; Zuo S; Zhou X; Feng Y; Sun Y; Yuan X
    Cancer Sci; 2019 Apr; 110(4):1194-1207. PubMed ID: 30690837
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.